Aberrant olfactory network functional connectivity in people with olfactory dysfunction following COVID-19 infection: an exploratory, observational studyResearch in context

Jed Wingrove; Janine Makaronidis; Ferran Prados; Baris Kanber; Marios C. Yiannakas; Cormac Magee; Gloria Castellazzi; Louis Grandjean; Xavier Golay; Carmen Tur; Olga Ciccarelli; Egidio D'Angelo; Claudia A.M. Gandini Wheeler-Kingshott; Rachel L. Batterham

EClinicalMedicine (Apr 2023)

Aberrant olfactory network functional connectivity in people with olfactory dysfunction following COVID-19 infection: an exploratory, observational studyResearch in context

Jed Wingrove,
Janine Makaronidis,
Ferran Prados,
Baris Kanber,
Marios C. Yiannakas,
Cormac Magee,
Gloria Castellazzi,
Louis Grandjean,
Xavier Golay,
Carmen Tur,
Olga Ciccarelli,
Egidio D'Angelo,
Claudia A.M. Gandini Wheeler-Kingshott,
Rachel L. Batterham

Affiliations

Jed Wingrove: Centre for Obesity Research, Department of Medicine, University College London, London, UK; National Institute for Health and Care Research, Biomedical Research Centre at UCLH and UCL, London, UK
Janine Makaronidis: Centre for Obesity Research, Department of Medicine, University College London, London, UK; National Institute for Health and Care Research, Biomedical Research Centre at UCLH and UCL, London, UK
Ferran Prados: National Institute for Health and Care Research, Biomedical Research Centre at UCLH and UCL, London, UK; NMR Research Unit, Queen Square MS Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, London, UK; Centre for Medical Image Computing, Department of Medical Physics and Biomedical Engineering, University College London, London, UK
Baris Kanber: National Institute for Health and Care Research, Biomedical Research Centre at UCLH and UCL, London, UK; NMR Research Unit, Queen Square MS Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, London, UK; Centre for Medical Image Computing, Department of Medical Physics and Biomedical Engineering, University College London, London, UK
Marios C. Yiannakas: NMR Research Unit, Queen Square MS Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, London, UK
Cormac Magee: Centre for Obesity Research, Department of Medicine, University College London, London, UK; National Institute for Health and Care Research, Biomedical Research Centre at UCLH and UCL, London, UK
Gloria Castellazzi: NMR Research Unit, Queen Square MS Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, London, UK; Brain Connectivity Research Centre, IRCCS Mondino Foundation, Pavia, Italy
Louis Grandjean: Department of Infection, Immunity & Inflammation, UCL Great Ormond Street Institute of Child Health, University College London, London, UK
Xavier Golay: NMR Research Unit, Queen Square MS Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, London, UK; Department of Brain Repair and Rehabilitation, UCL Queen Square Institute of Neurology, University College London, London, UK
Carmen Tur: NMR Research Unit, Queen Square MS Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, London, UK
Olga Ciccarelli: National Institute for Health and Care Research, Biomedical Research Centre at UCLH and UCL, London, UK; NMR Research Unit, Queen Square MS Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, London, UK
Egidio D'Angelo: Brain Connectivity Research Centre, IRCCS Mondino Foundation, Pavia, Italy; Department of Brain and Behavioural Sciences, University of Pavia, Pavia, Italy
Claudia A.M. Gandini Wheeler-Kingshott: NMR Research Unit, Queen Square MS Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, London, UK; Brain Connectivity Research Centre, IRCCS Mondino Foundation, Pavia, Italy; Department of Brain and Behavioural Sciences, University of Pavia, Pavia, Italy
Rachel L. Batterham: Centre for Obesity Research, Department of Medicine, University College London, London, UK; National Institute for Health and Care Research, Biomedical Research Centre at UCLH and UCL, London, UK; Corresponding author. Division of Medicine, University College London, Rayne Building, 5 University Street, London, WC1E 6JF, UK.

Journal volume & issue: Vol. 58
p. 101883

Abstract

Read online

Summary: Background: Olfactory impairments and anosmia from COVID-19 infection typically resolve within 2–4 weeks, although in some cases, symptoms persist longer. COVID-19-related anosmia is associated with olfactory bulb atrophy, however, the impact on cortical structures is relatively unknown, particularly in those with long-term symptoms. Methods: In this exploratory, observational study, we studied individuals who experienced COVID-19-related anosmia, with or without recovered sense of smell, and compared against individuals with no prior COVID-19 infection (confirmed by antibody testing, all vaccine naïve). MRI Imaging was carried out between the 15th July and 17th November 2020 at the Queen Square House Clinical Scanning Facility, UCL, United Kingdom. Using functional magnetic resonance imaging (fMRI) and structural imaging, we assessed differences in functional connectivity (FC) between olfactory regions, whole brain grey matter (GM) cerebral blood flow (CBF) and GM density. Findings: Individuals with anosmia showed increased FC between the left orbitofrontal cortex (OFC), visual association cortex and cerebellum and FC reductions between the right OFC and dorsal anterior cingulate cortex compared to those with no prior COVID-19 infection (p < 0.05, from whole brain statistical parametric map analysis). Individuals with anosmia also showed greater CBF in the left insula, hippocampus and ventral posterior cingulate when compared to those with resolved anosmia (p < 0.05, from whole brain statistical parametric map analysis). Interpretation: This work describes, for the first time to our knowledge, functional differences within olfactory areas and regions involved in sensory processing and cognitive functioning. This work identifies key areas for further research and potential target sites for therapeutic strategies. Funding: This study was funded by the National Institute for Health and Care Research and supported by the Queen Square Scanner business case.

Published in EClinicalMedicine

ISSN: 2589-5370 (Online)
Publisher: Elsevier
Country of publisher: United Kingdom
LCC subjects: Medicine: Medicine (General)
Website: https://www.thelancet.com/journals/eclinm/home

About the journal

Abstract

Keywords